The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
Titel:
The HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
Auteur:
Calkin, A. C. Giunti, S. Sheehy, K. J. Chew, C. Boolell, V. Rajaram, Y. S. Cooper, M. E. Jandeleit-Dahm, K. A.